DMSA study performed during febrile urinary tract infection: a predictor of patient outcome?
- 201 Downloads
Technetium-99m dimercaptosuccinic acid (DMSA) study has been advocated as a method for the assessment of renal sequelae after acute febrile urinary tract infection (UTI). However, it is not known whether DMSA scintigraphy performed during acute UTI has any prognostic value for outcome assessment. The objective of this study was to evaluate the usefulness of DMSA scintigraphy performed during UTI as a predictor of patient outcome, to identify children at risk of events [vesico-ureteral reflux (VUR) or recurrent UTI] that may lead to the development of progressive renal damage. One hundred and fifty-two children (including 78 girls) with a mean age of 20 months (range 1 month to 12 years) with first febrile UTI were evaluated by DMSA scintigraphy during acute UTI. After acute UTI, children were explored by voiding cysto-urethrography. Children who presented an abnormal DMSA study, or a normal DMSA study but VUR or recurrent UTI, underwent a DMSA control study 6 months after UTI. Children with VUR were followed up by direct radionuclide cystography. DMSA scintigraphy performed during acute UTI was normal in 112 children (74%). In 95 of these children, follow-up DMSA scintigraphy was not performed owing to a good clinical outcome. In the remaining 17 children, follow-up scintigraphy was normal. Forty children (26%) presented abnormal DMSA study during acute UTI. Twenty-five of them presented a normal follow-up DMSA, and 15 presented cortical lesions. Children with abnormal DMSA had a higher frequency of VUR than children with normal DMSA (48% vs 12%). It is concluded that children with normal DMSA during acute UTI have a low risk of renal damage. Children with normal follow-up DMSA and low-grade VUR have more frequent spontaneous resolution of VUR.
KeywordsDMSA scintigraphy Acute febrile urinary tract infection Vesico-ureteral reflux Recurrent urinary tract infection
- 3.Eggli DF, Tulchinsky M. Scintigraphic evaluation of pediatric urinary tract infection. Semin Nucl Med 1993; 3:199–218.Google Scholar
- 5.Merrick MV, Notghi A, Chalmers N, Wilkinson AG, Uttley WS. Long term follow up to determine the prognostic value of imaging after urinary tract infections. Part 1. Reflux. Arch Dis Child 1995; 72:388–392.Google Scholar
- 9.Piepsz A, Colarinha P, Gordon I, Hahn K, Olivier P, Roca I, Sixt R, van Persen J. Guidelines for99mTc-DMSA scintigraphy in children. Eur J Nucl Med 2001; 28:BP37–BP41.Google Scholar
- 18.Stokland E, Hellström M, Jacobsson B, Jodal U, Lundgreen P, Sixt R. Early99mTc dimercaptosuccinic acid (DMSA) scintigraphy in symptomatic first-time urinary tract infection. Acta Paedriat 1996; 85:430–436.Google Scholar
- 21.Ditchfield MR, Campo JF, Nolan TM, Cook DJ, Grimwood K, Powell HR, Sloane R, Cahill S. Risk factors in the development of early renal cortical defects in children with urinary tract infection. AJR 1994; 162:1393–1397.Google Scholar
- 26.Majd M, Rushton HG, Jantausch B, Wiedermann BL. Relationship among vesicoureteral reflux, P-fimbriated Escherichia coli, and acute pyelonephritis in children with febrile urinary tract infection. J Paediatr 1991; 119:578–585.Google Scholar
- 30.Camacho Marti V, Estorch Cabrera M, Caffaratti Sfulcini J, Fraga Rodriguez GM, Orsola De Los Santos A, Rodriguez Villamil L, Garat Barredo JM, Cubells Riero J, Carrio Gasset I. Role of direct radionuclide cystography and renal study by dimercaptosuccinic acid (DMSA) in the diagnosis and follow-up of vesicoureteral reflux. Rev Esp Med Nucl 2002; 21:269–274.PubMedGoogle Scholar
- 31.Sillen U. Vesicoureteral reflux in infants. Pediatr Nephrol 1999; 13:335–361.Google Scholar